| Title | Date | PubMed ID |
|---|
| Structure-based design of inhibitors of coagulation factor XIa with novel P1 moieties. | 2015 Apr 1 | 25728130 |
| Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor. | 2015 Feb 26 | 25587039 |
| Pyridine and pyridinone-based factor XIa inhibitors. | 2015 Feb 15 | 25592713 |
| Phenylimidazoles as potent and selective inhibitors of coagulation factor XIa with in vivo antithrombotic activity. | 2014 Dec 11 | 25405503 |
| Site-specific N-glycosylation analysis of human factor XI: Identification of a noncanonical NXC glycosite. | 2014 Nov | 25092234 |
| Allosteric inhibition of human factor XIa: discovery of monosulfated benzofurans as a class of promising inhibitors. | 2014 Apr 24 | 24666186 |
| Factor XI and traveling waves: the key to understanding coagulation in hemophilia? | 2013 Apr | 23547857 |
| High-resolution crystal structures of factor XIa coagulation factor in complex with nonbasic high-affinity synthetic inhibitors. | 2012 Apr 1 | 22505407 |
| Activated factor XI inhibits chemotaxis of polymorphonuclear leukocytes. | 2011 Nov | 21807745 |
| The role of factor XIa (FXIa) catalytic domain exosite residues in substrate catalysis and inhibition by the Kunitz protease inhibitor domain of protease nexin 2. | 2011 Sep 9 | 21778227 |